08:00 , Dec 3, 2012 |  BC Week In Review  |  Company News

Atonomics, Danaher deal

Atonomics said it received a milestone payment from Danaher's Beckman Coulter subsidiary under a May 2011 deal to develop diagnostics for Atonomics' Atolyzer immuno-diagnostic system. Atonomics said the payment was related to the achievement of...
07:00 , May 9, 2011 |  BC Week In Review  |  Company News

Atonomics, Beckman Coulter deal

Beckman Coulter partnered with Atonomics to develop diagnostics for Atonomics' Atolyzer immuno-diagnostic system. Atolyzer is in early development for use in a near-patient setting for indications including cardiovascular diseases, prostate cancer and maternal health. Atonomics...
23:53 , Aug 11, 2005 |  BC Extra  |  Financial News

Atonomics raises EUR 9 million

Diagnostics company Atonomics (Copenhagen, Denmark) raised EUR 4.5 million ($5.6 million) in the first tranche of a EUR 9 million ($11.1 million) private round. Investors included Inventages Venture Capital; Murata Manufacturing; NeuroSearch (CSE:NEUR); and Vaekstfonden....
07:00 , Jul 5, 2004 |  BC Week In Review  |  Company News

Atonomics ApS, NeuroSearch deal

Atonomics will acquire all the shares of NEUS subsidiary Azign Bioscience A/S (Ballerup, Denmark). NEUS retains exclusive rights to Azign's drug discovery technologies, and Atonomics has exclusive rights to the same technologies for diagnostics. Azign's...
07:00 , Jun 29, 2004 |  BC Extra  |  Company News

Atonomics acquires a NeuroSearch subsidiary

Diagnostic company Atonomics (Copenhagen, Denmark) will acquire all the shares of NeuroSearch's Azign Bioscience subsidiary. As part of the deal, NeuroSearch (CSE:NEUR) will retain exclusive rights to any remaining drug discovery technologies, while Atonomics will...